Randomized Clinical Trial Comparing Customized Corneal Crosslinking: Epi-on in High Oxygen and Epi-off in Room Air for Keratoconus.

Abstract

To compare clinical outcomes of customized transepithelial (epi-on) corneal crosslinking (CXL) in high oxygen and customized CXL with epithelial removal (epi-off) in room air for keratoconus (KC). Umeå University Hospital, Umeå, Sweden. Prospective, randomized, single-masked, intra-individually comparing study. Thirty-two participants with bilateral progressive KC were treated with bilateral customized topography-guided CXL, 30 mW/cm2; 7.2-15 J/cm2 and were randomized to epi-on in one eye (32 eyes) and epi-off in the fellow eye (32 eyes). Uncorrected (UDVA) and best corrected visual acuities (BCVA), maximal keratometry (Kmax), subjective ocular discomfort, low-contrast visual acuities (LCVA) at 10% and 2.5% contrast, ocular and anterior corneal wavefront aberrations, manifest refractive spherical equivalent (MRSE), endothelial cell count (ECC) and adverse events were assessed through 24 months. Both treatments showed improvements at 24 months in UDVA; -0.16 ± 0.24 (p < 0.001) and -0.13 ± 0.20 logMAR (p = 0.006), respectively, BCVA; -0.10 ± 0.11 (p < 0.001) and -0.10 ± 0.12 (p = 0.001), Kmax; -1.74 ± 1.31 (p < 0.001) and -1.72 ± 1.36 D (p < 0.001). LCVA 10% improved for both protocols (p < 0.001), but LCVA 2.5% improved for epi-on CXL only (p = 0.001). ECC was unaltered and no adverse events occurred. The epi-on eyes had significantly less discomfort symptoms during the whole first week posttreatment (p < 0.05). High-oxygen customized epi-on CXL is a viable alternative to room air customized epi-off CXL, with faster improvements in BCVA and LCVA and less early ocular discomfort.